Prosecution Insights
Prosecution Insights
15 pending office actions • 2 clients • 15 examiners • 14 art units • 0 of 15 (0%) have an AI response strategy ready • 26 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 15 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 15 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 8 (53%) |
| §102 only | 4 (27%) |
| §112 only | 2 (13%) |
| No statute on record | 1 (7%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FETTEROLF, BRANDON J | 1 | 49.5% | +14.6% |
| GILL, RACHEL B | 1 | 65.6% | +27.7% |
| GRAY, PHILLIP A | 1 | 74.0% | +10.6% |
| GRIZER, CASSANDRA SENN | 1 | 100.0% | +0.0% |
| FISHER, MELISSA L | 1 | 44.2% | +42.3% |
| QIAN, CELINE X | 1 | 47.9% | +16.8% |
| CRAIGO, BAHAR ALAWI | 1 | 46.9% | +27.0% |
| HERNANDEZ, JACKSON J | 1 | 52.8% | +51.5% |
| BOWLES, DAVID PAUL | 1 | 75.0% | +17.5% |
| PETERS, ALEC JON | 1 | 68.6% | +61.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18271901 | REPLICATION-COMPETENT ADENOVIRUS TYPE 4 SARS-COV-2 VACCINES AND THEIR USE | GRIZER, CASSANDRA SENN | 34d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17783171 | ANTIBODY-DRUG CONJUGATES SPECIFIC FOR CD276 AND USES THEREOF | PETERS, ALEC JON | 46d overdue |
| 18032132 | HIGH CONCENTRATION METHYLCOBALAMIN OR COMBINATION OF METHYL- AND HYDROXY-COBALAMIN FOR THE TREATMENT OF COBALAMIN C DEFICIENCY DISORDERS | CRAIGO, BAHAR ALAWI | 44d overdue |
| 18340863 | PEPTIDE HYDROGEL COMPRISING HYDROPHILIC AZIDE-CONTAINING AMINO ACID AND ITS USE | FISHER, MELISSA L | 35d overdue |
| 18275925 | ADJUVANTED MUCOSAL SUBUNIT VACCINES FOR PREVENTING SARS-COV-2 TRANSMISSION AND INFECTION | GILL, RACHEL B | 5d overdue |
| 18035240 | MODIFIED NK CELLS WITH REDUCED CCR5 EXPRESSION AND METHODS OF THEIR USE | QIAN, CELINE X | 13d |
| 17923394 | ABERRANT POST-TRANSLATIONAL MODIFICATIONS (PTMS) IN METHYL- AND PROPIONIC ACIDEMIA AND A MUTANT SIRTUIN (SIRT) TO METABOLIZE PTMS | BOWLES, DAVID PAUL | 13d |
| 18568738 | COMPOUNDS THAT BIND NON-CANONICAL G-QUADRUPLEX STRUCTURES AND METHODS OF MAKING AND USING THE SAME | FETTEROLF, BRANDON J | 16d |
| 18263394 | NEAR INFRARED PHOTOIMMUNOTHERAPY (NIR-PIT) COMBINATION THERAPY TO TREAT CANCER | GRAY, PHILLIP A | 33d |
| Client (Assignee) | Pending OAs |
|---|---|
| U.S. Government | 14 |
| Ash Stevens, LLC | 1 |
| Art Unit | Apps |
|---|---|
| 3783 | 2 |
| 1626 | 1 |
| 1671 | 1 |
| 1672 | 1 |
| 1658 | 1 |
| 1637 | 1 |
| 1699 | 1 |
| 1627 | 1 |
| 1654 | 1 |
| 1641 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18568738 | COMPOUNDS THAT BIND NON-CANONICAL G-QUADRUPLEX STRUCTURES AND METHODS OF MAKING AND USING THE SAME | The United States Department of Health and Human Services | FETTEROLF, BRANDON J | 1626 | §102 | Non-Final OA | 16d | Pending | Dec 08, 2023 |
| 18275925 | ADJUVANTED MUCOSAL SUBUNIT VACCINES FOR PREVENTING SARS-COV-2 TRANSMISSION AND INFECTION | The United States Of America, AS Represented By The Secretary, Depart. Of Health And Human Services | GILL, RACHEL B | 1671 | §102 | Non-Final OA | 5d overdue | Pending | Aug 04, 2023 |
| 18263394 | NEAR INFRARED PHOTOIMMUNOTHERAPY (NIR-PIT) COMBINATION THERAPY TO TREAT CANCER | The United States Department of Health and Human Services | GRAY, PHILLIP A | 3783 | §102 | Non-Final OA | 33d | Pending | Jul 28, 2023 |
| 18271901 | REPLICATION-COMPETENT ADENOVIRUS TYPE 4 SARS-COV-2 VACCINES AND THEIR USE | The United States Department of Health and Human Services | GRIZER, CASSANDRA SENN | 1672 | §103 | Non-Final OA | 34d | Pending | Jul 12, 2023 |
| 18340863 | PEPTIDE HYDROGEL COMPRISING HYDROPHILIC AZIDE-CONTAINING AMINO ACID AND ITS USE | The United States Department of Health and Human Services | FISHER, MELISSA L | 1658 | §112 | Non-Final OA | 35d overdue | Pending | Jun 25, 2023 |
| 18035240 | MODIFIED NK CELLS WITH REDUCED CCR5 EXPRESSION AND METHODS OF THEIR USE | The United States Department of Health and Human Services | QIAN, CELINE X | 1637 | §103 | Non-Final OA | 13d | Pending | May 03, 2023 |
| 18032132 | HIGH CONCENTRATION METHYLCOBALAMIN OR COMBINATION OF METHYL- AND HYDROXY-COBALAMIN FOR THE TREATMENT OF COBALAMIN C DEFICIENCY DISORDERS | The United States Department of Health and Human Services | CRAIGO, BAHAR ALAWI | 1699 | §103 | Non-Final OA | 44d overdue | Pending | Apr 14, 2023 |
| 18009571 | MONOMERIC AND OLIGOMERIC COMPOUND EMBODIMENTS AS CONTRACEPTIVES AND THERAPIES AND METHODS OF MAKING AND USING THE SAME | Ash Stevens, LLC | HERNANDEZ, JACKSON J | 1627 | §103 | Final Rejection | 56d | Pending | Dec 09, 2022 |
| 17923394 | ABERRANT POST-TRANSLATIONAL MODIFICATIONS (PTMS) IN METHYL- AND PROPIONIC ACIDEMIA AND A MUTANT SIRTUIN (SIRT) TO METABOLIZE PTMS | The United States Department of Health and Human Services | BOWLES, DAVID PAUL | 1654 | §103 | Non-Final OA | 13d | Pending | Nov 04, 2022 |
| 17783171 | ANTIBODY-DRUG CONJUGATES SPECIFIC FOR CD276 AND USES THEREOF | The United States Department of Health and Human Services | PETERS, ALEC JON | 1641 | Other | Final Rejection | 46d overdue | Pending | Jun 07, 2022 |
| 17632783 | CANCER DETECTION AND CLASSIFICATION | The United States Department of Health and Human Services | BUCHANAN, BAILEY CHEYENNE | 1682 | §103 | Final Rejection | 8d overdue | Pending | Feb 03, 2022 |
| 17631600 | RADIOLABELED SUGARS FOR IMAGING OF FUNGAL INFECTIONS | The United States Department of Health and Human Services | DONOHUE, SEAN R | 1618 | §112 | Non-Final OA | 35d overdue | Pending | Jan 31, 2022 |
| 17346630 | METHODS TO ELIMINATE CANCER STEM CELLS BY TARGETING CD47 | The United States Department of Health and Human Services | MATALKAH, FATIMAH KHALAF | 1638 | §102 | Final Rejection | 51d overdue | Pending | Jun 14, 2021 |
| 17260905 | INTRAOCULAR DELIVERY OF GENE THERAPY EXPRESSION VECTORS | The United States Department of Health and Human Services | DIOP, FATIMATA SAHRA | 3783 | §103 | Non-Final OA | 20d | Pending | Jan 15, 2021 |
| 16971288 | USE OF IL-34 TO TREAT RETINAL INFLAMMATION AND NEURODEGENERATION | The United States Of America, AS Represented By The Secretary, Department Of Health And Human SE | FONTAINHAS, AURORA M | 1675 | §103 | Non-Final OA | 73d overdue | Pending | Aug 19, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial